🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

57,46 USD

Máx. histórico

2.925,00

12012 días

Split 1:10 del 17/11/2011

Caída desde máximo

-98,04%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-6,80%

Cierre anterior

61,65

Rango de hoy

57,24 – 61,73

Volumen hoy

1.804.873

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,85%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 6 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/07/2019 29,02 29,64 29,01 29,52 +2,54% 2,15% 1.383.600
25/07/2019 29,23 29,37 28,69 28,79 -1,51% 2,33% 1.188.900
24/07/2019 29,67 29,68 28,45 29,23 -1,85% 4,15% 1.373.200
23/07/2019 30,06 30,35 29,16 29,78 -0,67% 3,95% 816.500
22/07/2019 29,28 30,73 29,15 29,98 +2,78% 5,40% 1.492.800
19/07/2019 29,66 29,98 29,13 29,17 -1,55% 2,87% 1.132.800
18/07/2019 28,57 30,13 28,44 29,63 +3,89% 5,90% 1.457.400
17/07/2019 28,44 28,74 27,94 28,52 +1,28% 2,81% 831.800
16/07/2019 27,81 28,33 27,60 28,16 +1,29% 2,62% 737.500
15/07/2019 27,27 27,98 26,94 27,80 +2,39% 3,81% 710.600
12/07/2019 26,29 27,21 25,95 27,15 +3,27% 4,79% 858.000
11/07/2019 26,73 26,75 26,10 26,29 -1,09% 2,43% 907.200
10/07/2019 26,96 27,27 26,18 26,58 -0,75% 4,05% 1.026.800
09/07/2019 26,18 26,96 26,18 26,78 +1,98% 2,98% 727.500
08/07/2019 26,24 26,39 25,78 26,26 -1,02% 2,32% 1.199.500
05/07/2019 26,76 26,76 26,26 26,53 -0,93% 1,87% 951.500
03/07/2019 26,42 26,79 26,42 26,78 +1,63% 1,40% 667.100
02/07/2019 26,53 26,78 26,02 26,35 -0,53% 2,86% 1.233.400
01/07/2019 26,79 27,00 25,68 26,49 -0,04% 4,93% 1.551.400
28/06/2019 28,20 28,30 26,05 26,50 -8,05% 7,98% 3.882.700
27/06/2019 28,30 28,84 27,69 28,82 +4,04% 4,06% 1.281.100
26/06/2019 27,70 28,00 27,35 27,70 +0,65% 2,33% 1.003.300
25/06/2019 27,69 27,90 27,24 27,52 +0,07% 2,38% 1.483.700
24/06/2019 28,13 28,28 27,33 27,50 -2,20% 3,38% 2.036.900
21/06/2019 27,28 28,46 27,05 28,12 +3,04% 5,17% 4.373.900
20/06/2019 27,82 28,32 27,10 27,29 -0,80% 4,37% 1.709.800
19/06/2019 27,98 28,19 27,29 27,51 -1,36% 3,22% 1.925.200
18/06/2019 26,78 27,97 26,70 27,89 +5,44% 4,74% 2.103.600
17/06/2019 26,01 26,57 25,95 26,45 +2,44% 2,38% 2.296.700
14/06/2019 26,10 26,10 25,69 25,82 -1,19% 1,57% 1.673.300